3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
66
NET
40
CNS
9
Gastrointestinal
7
Thoracic
5
Head & Neck
4
Genitourinary
4
Dermatologic
3
Sarcoma
1
Gynecologic
1
Conditions
Ovarian Neoplasms
1778
Uterine Cervical Neoplasms
1501
Endometrial Neoplasms
836
Breast Neoplasms
434
Carcinoma, Ovarian Epithelial
405
Fallopian Tube Neoplasms
400
Uterine Cervical Dysplasia
276
Neoplasms
253
Colorectal Neoplasms
180
Uterine Neoplasms
173
Peritoneal Neoplasms
170
Vulvar Neoplasms
155
Lung Neoplasms
150
Pancreatic Neoplasms
142
Prostatic Neoplasms
136
Recurrence
128
Stomach Neoplasms
126
Colonic Neoplasms
116
Papillomavirus Infections
115
Melanoma
101
Sarcoma
97
Urinary Bladder Neoplasms
95
Vaginal Neoplasms
93
Head and Neck Neoplasms
92
Carcinoma, Non-Small-Cell Lung
92
Neoplasm Metastasis
83
Esophageal Neoplasms
82
Testicular Neoplasms
80
Rectal Neoplasms
71
Kidney Neoplasms
62
Interventions
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoid Tumor
×
Gynecologic
×
Clear all
NCT06790706
2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2
Recruiting
154 enrolled